製品: osterix Antibody
カタログ: DF7731
タンパク質の説明: Rabbit polyclonal antibody to osterix
アプリケーション: WB IHC
反応性: Human, Mouse, Rat
予測: Pig, Bovine, Horse, Rabbit, Dog
分子量: 46 kDa; 45kD(Calculated).
ユニプロット: Q8TDD2
RRID: AB_2841199

類似製品を見る>>

   サイズ 価格 在庫状況
 100ul $280 在庫あり
 200ul $350 在庫あり

リードタイム: 当日配達

For pricing and ordering contact:
お問い合わせ先

製品説明

ソース:
Rabbit
アプリケーション:
WB 1:1000-3000, IHC 1:50-1:200
*The optimal dilutions should be determined by the end user.
*Tips:

WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.

反応性:
Human,Mouse,Rat
予測:
Pig(88%), Bovine(100%), Horse(100%), Rabbit(100%), Dog(88%)
クローナリティ:
Polyclonal
特異性:
osterix Antibody detects endogenous levels of total osterix.
RRID:
AB_2841199
引用形式: Affinity Biosciences Cat# DF7731, RRID:AB_2841199.
コンジュゲート:
Unconjugated.
精製:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
別名:

折りたたみ/展開

MGC126598; Osterix; Osx; Sp 7; SP7; Sp7 transcription factor; SP7_HUMAN; Transcription factor Sp7; Zinc finger protein osterix;

免疫原

免疫原:
Uniprot:
遺伝子(ID):
発現特異性:
Q8TDD2 SP7_HUMAN:

Restricted to bone-derived cell.

タンパク質配列:
MASSLLEEEVHYGSSPLAMLTAACSKFGGSSPLRDSTTLGKAGTKKPYSVGSDLSASKTMGDAYPAPFTSTNGLLSPAGSPPAPTSGYANDYPPFSHSFPGPTGTQDPGLLVPKGHSSSDCLPSVYTSLDMTHPYGSWYKAGIHAGISPGPGNTPTPWWDMHPGGNWLGGGQGQGDGLQGTLPTGPAQPPLNPQLPTYPSDFAPLNPAPYPAPHLLQPGPQHVLPQDVYKPKAVGNSGQLEGSGGAKPPRGASTGGSGGYGGSGAGRSSCDCPNCQELERLGAAAAGLRKKPIHSCHIPGCGKVYGKASHLKAHLRWHTGERPFVCNWLFCGKRFTRSDELERHVRTHTREKKFTCLLCSKRFTRSDHLSKHQRTHGEPGPGPPPSGPKELGEGRSTGEEEASQTPRPSASPATPEKAPGGSPEQSNLLEI

種類予測

種類予測:

Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.

Species
Results
Score
Horse
100
Bovine
100
Rabbit
100
Pig
88
Dog
88
Sheep
0
Xenopus
0
Zebrafish
0
Chicken
0
Model Confidence:
High(score>80) Medium(80>score>50) Low(score<50) No confidence

PTMs - Q8TDD2 基板として

Site PTM Type Enzyme
S30 Phosphorylation
S31 Phosphorylation
T37 Phosphorylation
T38 Phosphorylation
K41 Ubiquitination
S49 Phosphorylation
S52 Phosphorylation
K58 Ubiquitination
S76 Phosphorylation Q16539 (MAPK14)
S80 Phosphorylation Q16539 (MAPK14)
K230 Ubiquitination
S237 Phosphorylation
K307 Acetylation
K312 Acetylation
T319 Phosphorylation
S338 Phosphorylation
T364 Phosphorylation
S366 Phosphorylation
S370 Phosphorylation
S396 Phosphorylation
T397 Phosphorylation
S422 Phosphorylation

研究背景

機能:

Transcriptional activator essential for osteoblast differentiation. Binds to SP1 and EKLF consensus sequences and to other G/C-rich sequences (By similarity).

Transcriptional activator essential for osteoblast differentiation. Binds to SP1 and EKLF consensus sequences and to other G/C-rich sequences.

PTMs:

Ubiquitination at leads to proteasomal degradation. SP7 is a short-live protein with an endogenous half-life of approximately 12 hours.

Propionylated. Depropionylation at Lys-371 by SIRT7 activates transcription factor activity and positively regulates bone formation by osteoblasts.

細胞の位置付け:

Nucleus.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
組織特異性:

Restricted to bone-derived cell.

サブユニット構造:

Interacts with RIOX1; the interaction is direct and inhibits transcription activator activity.

タンパク質ファミリー:

The 9aaTAD motif is a transactivation domain present in a large number of yeast and animal transcription factors.

Belongs to the Sp1 C2H2-type zinc-finger protein family.

参考文献

1). Gene-Activating Framework Nucleic Acid- Targeted Upregulating Sirtuin‑1 to Modulate Osteoimmune Microenvironment for Diabetic Osteoporosis Therapeutics. ACS Nano, 2024 [IF=15.8]

2). Gene-Activating Framework Nucleic Acid- Targeted Upregulating Sirtuin‑1 to Modulate Osteoimmune Microenvironment for Diabetic Osteoporosis Therapeutics. ACS Nano, 2024 [IF=15.8]

3). Vascular Derived ECM Improves Therapeutic Index of BMP‐2 and Drives Vascularized Bone Regeneration. Small, 2022 (PubMed: 35218305) [IF=13.0]

4). Prenatal dexamethasone exposure reduces osteoprogenitor proliferation in mice via histone modifications at the Mkp-1 gene locus. Communications biology, 2024 (PubMed: 39609620) [IF=5.9]

5). Hypoxia‑induced mitophagy regulates proliferation, migration and odontoblastic differentiation of human dental pulp cells through FUN14 domain‑containing 1. International Journal of Molecular Medicine, 2022 (PubMed: 35362539) [IF=5.7]

Application: WB    Species: Human    Sample: HDPCs

Figure 3 Hypoxia promotes proliferation, migration and odontoblastic differentiation in HDPCs. (A) Representative images of wound healing assays in the normoxic or hypoxic group. Scale bar, 1 mm. (B) Percentages of wound closure from three independent experiments are quantified. (C) Representative images of migratory cells stained with crystal violet. (D) Statistical quantification of the number of migratory cells from three independent experiments are shown. Scale bar, 100 µm. (E) Cell viability of HDPCs was detected using Cell Counting Kit-8 analysis. (F) ALP staining and (G) activity in the normoxic or hypoxic group on day 3. Scale bar, 200 µm. (H) Representative western blotting images showing the protein expression levels of RUNX2, Col I, OSX and OPN in the normoxic or hypoxic group on day 3, (I) which were quantified. Results are presented as the means ± SD from ≥ three independent experiments. **P<0.01 and ***P<0.001 vs. normoxia. Nor, normoxia; Hypo, hypoxia; OD, optical density; ALP, alkaline phosphatase; RUNX2, runt-related transcription factor 2; Col I, collagen type I; OSX, osterix; OPN, osteopontin.

6). Isolation and characterization of a novel homopolysaccharide (SFP-1) from Sargassum fusiforme: Promising anti-osteoporosis activity by modulating adipo-osteogenic differentiation. Industrial Crops and Products, 2024 [IF=5.6]

7). Dynamic expression of IGFBP3 modulate dual actions of mineralization micro-environment during tooth development via Wnt/beta-catenin signaling pathway. Biology Direct, 2023 (PubMed: 37365579) [IF=5.5]

Application: WB    Species: Human    Sample: hDPSCs

Fig. 3 Effects of over-expressed IGFBP3 on odontogenic and osteogenic differentiation of human dental papilla stem cells and dental mesenchyme. A IGFBP3 expression in lv5 hDPSCs versus IGFBP3-over hDPSCs after lentivirus transfection (a); Relative expression of DSPP, DMP1, OSX, OPN, OCN and ALP in lv5 hDPSCs versus IGFBP3-over hDPSCs after 0 days (b), 4 days (c) and 7 days (d) osteogenic induction. B The IGFBP3 expression response to osteogenic induction was investigated by RT-qPCR using hDPSCs. C The protein levels of IGFBP3, odontogenic and osteogenic markers in lv5 hDPSCs and IGFBP3-over hDPSCs were detected by Western blot analysis (a). Quantitative analysis of the relative protein expression in IGFBP3 (b1), DSPP (b2), OSX (b3), OPN (b4), OCN (b5) and ALP (b6). D Alizarin red staining of lv5 hDPSCs and IGFBP3-over hDPSCs with 14 days osteogenic induction; Alkaline phosphatase staining of lv5 hDPSCs and IGFBP3-over hDPSCs treated with osteogenic induction medium for 7 days. Microscopic views: a1–d1, scale bar 200 μm; gross views: a2–d2. E Microscopic views of dental mesenchymal tissue from the P1 tooth germ with lentivirus transfection (a). Relative expression of Igfbp3, Dspp, Ocn in lv5 dental mesenchyme and IGFBP3-over dental mesenchyme were detected by RT-qPCR (b). lv5, hDPSCs or dental mesenchyme with empty pGLV5 vector control; over, hDPSCs or dental mesenchyme with IGFBP3 overexpressing vector. n = 3

8). MiR‐19b‐3p accelerates bone loss after spinal cord injury by suppressing osteogenesis via regulating PTEN/Akt/mTOR signalling. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021 (PubMed: 33332749) [IF=5.3]

Application: WB    Species: rat    Sample: BMSCs

FIGURE 2|MiR-19b-3p overexpression inhibited osteogenic differentiation of BMSCs. (A) RT-PCR was used to detect miR-19b-3p expression in BMSC-derived osteoblast after transduction. Western blot for (B) osterix andosteocalcin in BMSC-derived osteoblasts after transduction.

9). Metformin suppresses oxidative stress induced by high glucose via activation of the Nrf2/HO-1 signaling pathway in type 2 diabetic osteoporosis. LIFE SCIENCES, 2023 (PubMed: 36279968) [IF=5.2]

10). The effect of MMP-2 inhibitor 1 on osteogenesis and angiogenesis during bone regeneration. Frontiers in Cell and Developmental Biology, 2021 (PubMed: 33553142) [IF=4.6]

Application: WB    Species: human    Sample: hBMSCs

FIGURE 2 | The effects of MMP2-I1 on osteogenesis of hBMSCs. (H–K) The expression of RUNX2, COL1A1 and OSX proteins were determined by Western blot analysis after osteogenic differentiation for 3 and 7 days. All the data were confirmed by three repeated tests. Data were mean ± S.D.*p < 0.05 vs. the control group at the same day. #p < 0.05 vs. the control group at the same day. Scale bar = 500µm.

もっと読みます

Restrictive clause

 

Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.

For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.